CD274 and non-small cell lung carcinoma: Despite the difference in TMB, the levels of PD-L1 were largely similar across ancestry groups, where approximately 30% of the overall non-Sq NSCLC cohort had PD-L1 expression of ≥50%, with an additional 30% showing expression levels 1–49% (Fig. 4b).